Background: Hepatitis A virus (HAV), an atypical Picornaviridae that causes acute hepatitis in humans, usurps the HAV cellular receptor 1 (HAVCR1) to infect cells. HAVCR1 is a class 1 integral membrane glycoprotein that contains two extracellular domains: a virus-binding immunoglobulin-like (IgV) domain and a mucin-like domain that extends the IgV from the cell membrane. Soluble forms of HAVCR1 bind, alter, and neutralize cell culture-adapted HAV, which is attenuated for humans. However, the requirements of the HAV-HAVCR1 interaction have not been fully characterized, and it has not been determined whether HAVCR1 also serves as a receptor for wild-type (wt) HAV. Here, we used HAV soluble receptor neutralization and alteration assays to study the requirements of the HAV-HAVCR1 interaction and to determine whether HAVCR1 is also a receptor for wt HAV. Results: Treatment of HAV with a soluble form of HAVCR1 that contained the IgV and two-thirds of the mucin domain fused to the Fc fragment of human IgG1 (D1 muc-Fc), altered particles at 37°C but left a residual level of unaltered particles at 4°C. The kinetics of neutralization of HAV by D1 muc-Fc was faster at 37°C than at 4°C. Alteration of HAV particles by D1 muc-Fc required Ca, which could not be replaced by Li, Na, Mg, Mn, or Zn. Neutralization of HAV by D1 muc-Fc occurred at pH 5 to 8 but was more efficient at pH 6 to 7. D1 muc-Fc neutralized wt HAV as determined by a cell culture system that allows the growth of wt HAV. Conclusion: The interaction of HAV with soluble forms of HAVCR1 shares the temperature, Ca, and pH requirements for infectivity in cell culture and therefore mimics the cell entry process of HAV. Since soluble forms of HAVCR1 also neutralized wt HAV, this receptor may play a significant role in pathogenesis of HAV.
Chagas disease, caused by Trypanosoma cruzi, progresses through acute and chronic phases and is characterized by parasite persistence in multiple tissues, including the heart, gastrointestinal tract, and skeletal muscle. Digestive Chagas disease (DCD) is associated with pathological alterations in the colon during chronic infection. To characterize the immune landscape underlying this process, we used a murine model of chronic DCD and performed single-cell RNA sequencing of colonic lamina propria cells. Our analysis revealed infiltration of T cells, B cells, and macrophages, with T cells representing the predominant immune population in the chronically infected colon. Computational inference of cell-cell communication predicted strong activation of the CCL chemokine signaling pathway, with the CCL5-CCR5 axis emerging as a potential mediator of interactions between CD8+ cytotoxic T cells and macrophages. These findings highlight the importance of chemokine-driven immune coordination in chronic infection and provide a foundation for the identification of biomarkers and the development of targeted therapeutic strategies for chronic DCD.
Leishmaniasis lacks an effective vaccine. We developed a live-attenuated Leishmania major Centrin-deficient strain (LmCen-/-) that is safe and protective in murine and canine models through IFN-γ-producing effector T cells. Because persistent low-level infection supports durable immunity, we investigated latent parasites and immune remodeling in the bone marrow. Dual single-cell RNA sequencing detected parasitized bone marrow cells 28 days after intradermal inoculation with either virulent LmWT or attenuated LmCen-/-. Flow cytometry showed increased myelopoiesis following LmCen-/- immunization compared with LmWT infection. Cell-cell communication analysis implicated enhanced granulin-Sort3 signaling as a potential driver of this response. Bone marrow monocytes from LmCen-/--immunized mice efficiently cleared virulent LmWT parasites in co-culture, consistent with the induction of trained innate immunity. These findings identify the bone marrow as an active site of anti-Leishmania immune programming and suggest that LmCen-/- vaccination promotes durable protection through coordinated adaptive and innate mechanisms.